From: Emerging role of circular RNAs in the pathogenesis of ovarian cancer
circRNA | Clinical samples/animal model | Assessed cell lines | Targets/regulators/signaling pathways | Description | References |
---|---|---|---|---|---|
CircMUC16 | 3 EOC tissues and 4 healthy ovarian tissues/6-week-old BALB/c nude mice | SKOV3, ES-2, A2780 and CAOV-3 | miR-199a-5p, Beclin1, RUNX1 and ATG13 | ↑↑ circMUC16: ↑ autophagy flux of SKOV3 cells ↑ autophagy flux of SKOV3 cells: ↑ EOC invasion and metastasis | [9] |
circRNA_MYLK | 46 pairs of tumor tissues and ANCTs | SKOV3, OVCAR3, PEO1, 3AO, A2780, CAOV3 and HOSEPiCs | miR-652 | Patients with high levels of circRNA_MYLK showed a higher pathological staging and a lower OS rate ∆ circRNA_MYLK: ↓ cell proliferation | [10] |
circRNA-UBAP2 | 20 pairs of tumor tissues and ANCTs | SKOV3, No. KL; OVCAR-3, No. H-OVCAR-3; ES-2, No. H-ES-2 and A2780, No. H-A2780 and IOSE80 | miR-382-5p/PRPF8 axis | ↑↑ circRNA-UBAP2: ↑ proliferation and ↓ apoptosis via sponging miR-382 | [11] |
circRNA-UBAP2 | 24 pairs of tumor tissues and ANCTs | A2780, HEY, OVCAR3, HO8910, SKOV3 and IOSE | miR-144 | Expression of circRNA-UBAP2 was negatively associated with TMN stage and five-year survival of OC patients ↑↑ circRNA-UBAP2: ↑ proliferation and migration via sponging miR-144 | [12] |
circWHSC1 | 79 patients and 13 healthy controls/4-week-old female BALB/c nude mice | CAOV3 and OVCAR3 | miR-145, miR-1182, MUC1 and hTERT | ↑↑ circWHSC1: ↑ cell proliferation, migration and invasion, and ↓ cell apoptosis via sponging miR-145 and miR-1182 | [14] |
Hsa_circ_0013958 | 45 pairs of tumor tissues and ANCTs | A2780, OVCAR‐3 and HOSEpiC | – | High levels of Hsa_circ_0013958 were related to patient FIGO stage and lymph node metastasis ∆ hsa_circ_0013958: ↓ proliferation, migration, and invasion and ↑ apoptosis | [15] |
Circ_0013958 | 30 pairs of tumor tissues and ANCTs/5-week-old female BALB/c nude mice | HOSE, SKOV3 and CAOV3 | miR-637/PLXNB2 axis | ∆ circ_0013958: ↓ proliferation, migration, invasion, and ↑ apoptosis | [16] |
circFGFR3 | 35 pairs of tumor tissues and ANCTs | OSE, SKOV3, A2780, OV2008 and IGROV1 | miR-29a-3p/E2F1 axis | ↑↑ circFGFR3: ↑ EMT process | [17] |
hsa_circRNA_102958 | 41 pairs of tumor tissues and ANCTs | OC cell lines and IOSE80 cells | miR-1205/SH2D3A axis | ∆ hsa_circRNA_102958: ↓ proliferation, migration and invasion | [18] |
circ_0072995 | 40 pairs of tumor tissues and ANCTs/4 to 6-week-old BALB/c nude mice | HO8910, A2780, and IOSE80 | miR-147a/CDK6 axis | ↑↑ circ_0072995: ↑ cell proliferation, migration and ↓ apoptosis | [19] |
circ_0072995 | 47 pairs of tumor tissues and ANCTs/6-week-old female BALB/c nude mice | IOSE-80, OVCAR-3 and SK-OV-3 | miR-122-5p/SLC1A5 axis | ∆ circ_0072995: ↓ cell proliferation, migration, invasion and ↑ cell apoptosis | [20] |
circEPSTI1 | 50 pairs of tumor tissues and ANCTs/4‐week‐old BALB/c nude mice | – | miR-942/EPSTI1 axis | ∆ circEPSTI1: ↓ cell proliferation, invasion and ↑ apoptosis | [21] |
circ-LOPD2 | normal ovarian tissue, benign tumor, borderline tumor and ovarian cancer tissues | CAOV3, A2780 and OVCAR3 | miR-378 | ∆ circ-LOPD2: ↓ cell growth | [22] |
circGFRA1 | 50 pairs of tumor tissues and ANCTs/4-week old BALB/c nude mice | OV119 and A2780 | miR-449a/ GFRA1 axis | ∆ circGFRA1: ↓ cell proliferation and invasion and ↑ apoptosis | [23] |
circ0004390 | 10 ovarian cancer tissues and 6 normal ovarian tissues | KOV3, HeyA8, OVCAR429 and HEK- 293 T | miR-198/MET axis | ∆ circ0004390: ↓ proliferation | [24] |
circKIF4A | 50 pairs of tumor tissues and ANCTs/4-week-old female BALB/c nude mice | CAOV3 and SKOV3 | miR-127/ JAM3 axis | ∆ circKIF4A: ↓ cell proliferation and migration | [25] |
circ_0000554 | – | HO8910 | miR-567 | ↑↑ circ_0000554: ↑ cell growth, invasion, and EMT process | [26] |
circKRT7 | 5-week-old BALB/c mice | SKOV3, ES-2, CoC1, Caov-3, and Caov-4 | miR-29a-3p/COL1A1 axis | ∆ circKRT7: ↓ cell proliferation, migration and invasion via sponging miR-29a-3p | [27] |
circCELSR1 | 4-week-old female athymic nude mice | SKOV3, A2780, IGROV1, CAOV3, and IOSE80 | miR-598/ BRD4 axis | ∆ circCELSR1: ↓ proliferation, migration, invasion and EMT process and ↑ apoptosis | [28] |
circCELSR1 | 36 pairs of tumor tissues and ANCTs/6-week-old female BALB/c athymic nude mice | SKOV3, HeyA-8 and IOSE-80 | miR-1252/FOXR2 axis | ∆ circCELSR1: ↓ cell growth, ↑ G0/G1 arrest and apoptosis | [29] |
circCELSR1 | – | – | miR-149-5p/SIK2 axis | ∆ circCELSR1: ↓ viability, colony formation and cell cycle process, ↑ paclitaxel sensitivity and cell apoptosis | [30] |
circHIPK3 | 69 pairs of tumor tissues and ANCTs | A2780, HO8910, SKOV3, CAOV3 and HOEC | – | Patients with higher levels of circHIPK3 showed lymph node invasion, FIGO stage, and worse DFS and OS | [31] |
circHIPK3 | 66 pairs of tumor tissues and ANCTs | SKOV3 | miR-7/VEGF axis | ∆ circHIPK3: ↓ tumorigenicity of ovarian cancer cells, proliferation and ↑ apoptosis | [32] |
circRAB11FIP1 | ovarian cancer tissues and serum samples from 70 EOC and 30 matched non-carcinoma tissue samples/6-week-old BALB/c nude mice | SKOV3 | miR-129/ ATG7 and ATG14 | ∆ circRAB11FIP1: ↓ autophagic flux of ovarian cancer SKOV3 cells ↑↑ circRAB11FIP1: ↑ autophagy, proliferation and invasion | [13] |
Hsa_circ_0009910 | 50 pairs of tumor tissues and ANCTs | SKOV3 | miR-145 | Hsa_circ_0009910 induces proliferative and motile phenotypes via sponging miR-145 in ovarian cancer cells | [33] |
circASH2L | 50 pairs of tumor tissues and ANCTs/4-week-old female athymic BALB/c nude mice | A2780, TOV112D, OVCAR-3, SKOV3 and ISOE80 | miR-665/VEGFA axis | ∆ circASH2L: ↓ invasion and cell growth in vitro, angiogenesis and lymphangiogenesis in vivo | [34] |
circ-PGAM1 | 15 EOC tissues and 15 normal ovary tissues/nude mice | CAOV3, SKOV3, OVCAR3, ES‐2 and 293T cells | miR-542-3p/CDC5L/PEAK1 pathway | ∆ circ-PAGM1: ↓ proliferation, migration, and invasion of ovarian cancer cells and ↑ apoptosis | [35] |
circRhoC | 127 ovarian cancer tissues and 24 normal ovarian tissues | A2780 cells | miR-302e/ VEGFA axis | ↑↑ circRhoC: ↑cell viability, migration and invasion via sponging miR-302e | [36] |
circPUM1 | 62 EOC and 13 normal ovarian tissues/5-week-old female BALB/c nude mice | A2780, CAOV3 and HMrSV5 | miR-615-5p, miR-6753-5p, NF-κB and MMP2 | ↑↑ circPUM1: ↑ proliferation, migration, and invasion and ↓ apoptosis CircPUM1 showed to act on the peritoneum and increase metastasis of cancer in the form of cancer-derived exosomes | [37] |
circ_0007841 | 43 pairs of tumor tissues and ANCTs/6-week-old BALB/c nude mice | SKOV3, OVCAR3 and IOSE80 | miR-151-3p/MEX3C axis | ∆ circ_0007841: ↓ proliferation, migration and invasion | [38] |
hsa_circ_0026123 | 20 pairs of tumor tissues and ANCTs/4 weeks old female BALB/c nude mice | A2780, TOV112D, SKOV3, OVCAR-3 and ISOE80 | miR-124-3p/EZH2 axis | ∆ hsa_circ_0026123: ↓ proliferation and metastasis | [39] |
circFoxp1 | 112 EOC patients and 82 healthy controls/nude mice | COC1, OVCAR3, SKOV3, SKOV3/DDP and IOSE-80 | miR-22, miR-150-3p, CEBPG and FMNL3 | ↑↑ circFoxp1: ↑ proliferation and DDP resistance High levels of circFoxp1 were correlated with lymphatic metastasis, distant metastasis, FIGO stage, primary tumor size, residual tumor diameter, and clinical response | [40] |
CircCRIM1 | 130 ovarian cancer tissues and 24 normal ovarian tissues/4-week-old female BALB/c nude mice | OVCAR3 and CAOV3 | miR-145-5p, miR-383-5p, CRIM1 and ZEB2 | ↑↑ CircCRIM1: ↑ cancer progression in vitro and tumor growth in vivo | [41] |
hsa_circ_0061140 | 4-week-old male BALB/c nude mice | SKOV3 and A2780 | miR-370/FOXM1 axis | ∆ hsa_circ_0061140: ↓ proliferation and migration | [42] |
circ_0061140 | 20 PTX-resistant human ovarian cancer tissues and 19 PTX-sensitive human ovarian cancer tissues/5-week-old female BALB/c nude mice | SKOV3, HeyA8 and IOSE-80 | miR-136/CBX2 axis | ∆ circ_0061140: ↓ proliferation, migration and invasion, and ↑ apoptosis and PTX sensitivity | [43] |
circ-PVT1 | GTEx database | SKOV3 and A2780 | miR-149-5p/FOXM1 axis | ∆ circ-PVT1: ↓ proliferation, migration and invasion High levels of PVT1 were correlated with shorter OS in OV patients | [44] |
circ-PVT1 | – | CAOV3, SKOV3, SNU119, OVCAR3 and HOSEpiC | miR-149 | ∆ circ-PVT1: ↓ proliferation and ↑ apoptosis ↑↑ circ-PVT1: ↑ proliferation and ↓ apoptosis | [45] |
circ_0015756 | 55 pairs of tumor tissues and ANCTs/5-week-old female BALB/c nude mice | OV90, SKOV3 and IOSE80 | miR-942-5p/CUL4B axis | ∆ circ_0015756: ↓ proliferation, migration and invasion and ↑ apoptosis | [46] |
circ_0025033 | 39 pairs of tumor tissues and ANCTs/6–8 weeks old female BALB/c mice | KOV3 and A2780 and IOSE80 | miR-184/LSM4 axis | ∆ circ_0025033: ↓ colony formation, migration, invasion and glycolysis metabolism | [47] |
circ_0005276 | 49 pairs of tumor tissues and ANCTs | CAOV3 and SKOV3 | ADAM9 | ∆ circ_0005276: ↓ migration High levels of circ_0005276 were associated with lymphatic metastasis and distant metastasis in EOC patients | [48] |
circ-NOLC1 | 118 ovarian cancer tissues, 11 borderline tumor tissues, 11 benign ovarian tissues, 15 normal ovarian tissues/5-week-old female BALB/c nude mice | A2780, CAOV3, ES-2, HO8910, OVCAR3, and SKOV3 | ESRP1, CDK1 and RhoA | ↑↑ circ-NOLC1: ↑ proliferation, migration, and invasion tumor growth by binding ESRP1 and modulating CDK1 and RhoA expression | [49] |
circBIRC6 | – | SKOV3, SKOV3/DDP | miR-367-3p | ∆ circBIRC6: ↓ proliferation of ovarian cancer cisplatin-resistant cells and ↑ apoptosis | [50] |
circ-0001068 | 20 pairs of tumor tissues and ANCTs 95 OC patients and 53 healthy controls | – | miR-28-5p | Circ-0001068 was found to be delivered into T cells and induced PD1 expression by sponging miR-28-5p | [51] |
circRNA051239 | 30 EOC patients and 10 healthy controls | SKOV3.ip, SKOV3, A2780, CAOV3 and OVCAR3 | miR-509-5p/PRSS3 axis | ∆ circRNA051239: ↓ proliferation and migration | [52] |
circVPS13C | 40 pairs of tumor tissues and ANCTs | A2780, SKOV3 and IOSE-80 | miR-145 and MEK/ERK signaling | Propofol treatment: ↓ circVPS13C levels and ↑ miR-145 levels, thus ↓ viability, cell cycle and motility and ↑ apoptosis | [53] |
circANKRD12 | – | PA-1, SKOV3, Caov3, NIH:OVCAR-3 and APOCC | – | Downregulation of circANKRD12 compelled a strong phenotypic change in cell cycle, invasion and migration and metabolism in cancer cells | [54] |
VPS13C-has-circ-001567 | 20 pairs of tumor tissues and ANCTs | SKOV3 and OV-1063 | – | ∆ VPS13C-has-circ-001567: ↓ proliferation, tumorigenicity and ↑ apoptosis High levels of VPS13C-has-circ-001567 were associated with tumor node metastasis stage and lymph node metastasis | [55] |
circPIP5K1A | 25 pairs of tumor tissues and ANCTs/4-week-old BALB/c nude mice | VCAR5, SKOV3, A2780, OV2008 and HCerEpiC | miR-661/IGFBP5 axis | ∆ circPIP5K1A: ↓ proliferation, migration and invasion | [56] |
circATL2 | – | PTX-resistant OC tissues and cells | miR-506-3p/NFIB axis | ∆ circATL2: ↓ colony formation, resistance of OC to PTX and ↑ cell cycle arrest and apoptosis in PTX-resistant OC cells | [57] |
hsa_circ_0004712 | 30 pairs of tumor tissues and ANCTs/4–6 weeks old female BALB/c mice | OVCAR-3, SKOV-3 and IOSE-80 | miR-331-3p/FZD4 axis | ∆ hsa_circ_0004712: ↓ proliferation, colony formation, invasion and migration, and ↑ apoptosis | [58] |
CiRS-7 | 40 pairs of tumor tissues and ANCTs/4-week-old male BALB/c nude mice | SKOV3, A2780, OV2008, IGROV1, ES-2 and HOSE | miR-641/ZEB1 or miR-641/MDM2 axis | ∆ CiRS-7: ↓ cell growth and metastasis High levels of CiRS-7 were correlated with the TNM stages, lymph node metastasis status and overall survival rate in OC patients | [59] |
circ-PTK2 | 26 ovarian cancer tissues and 11 normal ovary tissues/4–5-week-old female nude mice | SK-OV-3 and OVCAR-3 | miR-639/FOXC1 axis | ↑↑ circ-PTK2: ↑tumor formation, migration and invasion and EMT process | [60] |
circLNPEP | 40 pairs of tumor tissues and ANCTs/4-week-old male BALB/c nude mice | A2780, SKOV-3, OVCAR3, SK-BR-3, OV-56 and TOV-21 G | miR-876-3p/WNT5A axis | ∆ circLNPEP: ↓ cell viability, proliferation, migration, invasion, angiogenesis, and EMT process and ↑ apoptosis | [61] |
circNRIP1 | 56 pairs of tumor tissues and ANCTs/BALB/c nude mice | HOEC, A2780, SKOV3 and A2780/PTX and SKOV3/PTX | miR-211-5p/HOXC8 axis | ∆ circNRIP1: ↓ PTX resistance of OC cells in vitro and OC tumor in vivo | [62] |
circTNPO3 | 48 pairs of tumor tissues and ANCTs/nude mice | SKOV3, HeyA-8 and IOSE-80 | miR-1299/NEK2 axis | ∆ circTNPO3: ↑ sensitivity to PTX via promoting PTX-induced apoptosis in vitro and in vivo | [63] |
hsa_circ_0051240 | 10 pairs of tumor tissues and ANCTs/6-week-old male nude mice | CAOV-3, SKOV-3, OVCAR-3 and H8910 and HOSE | miR-637/KLK4 axis | ∆ hsa_circ_0051240: ↓ cell proliferation, migration and invasion in vitro, and tumor formation in vivo | [64] |
circSETDB1 | 73 pairs of tumor tissues and ANCTs/4–6-week-old female BALB/c nude mice | A2780, SKOV3, IOSE-80 and 293 T cells | miR-129-3p/MAP3K3 pathway | ∆ circSETDB1: ↓ cell proliferation, migration, invasion and ↑ apoptosis | [65] |
circSETDB1 | 60 SOC patients [18 primary chemoresistance, 42 primary chemosensitive] and 60 healthy controls | – | – | High levels of circSETDB1 Were correlated with advanced clinical stage, lymph node metastasis and a shorter PFS time of SOC patients | [66] |
hsa_circ_0000714 | – | SKOV3, A2780, SKOV3/PTX and A2780/PTX | miR-370-3p/RAB17 axis and CDK6/RB signaling pathway | Hsa_circ_0000714 was found to regulate RAB17 expression via sponging miR-370-3p, and through the CDK6/RB signaling pathway, so it showed to play a role in the malignant progression of the paclitaxel-resistant ovarian cancer cell A2780/PTX | [67] |
circ_MUC16 | 30 pairs of tumor tissues and ANCTs/female BALB/c nude mice | A2780, SK-OV-3 and IOSE-80 | miR-1182/S100B axis | ∆ circ_MUC16: ↓ proliferation, glycolysis metabolism, migration and invasion ↑↑ circ_MUC16: ↓ effects of Propofol to promote the aggressive behaviors of ovarian cancer via sponging miR-1182 | [68] |
circ-FAM53B | 54 pairs of tumor tissues and ANCTs | HO8910, SKOV3, OVCAR3, A2780 and IOSE80 | miR-647, VAMP2 and MDM2 | ↑↑ circ-FAM53B: ↑ proliferation, migration, and invasion High levels of circ-FAM53B were correlated with clinical severity and poor prognosis of OC patients | [69] |
circ-ABCB10 | 103 EOC tumor tissues and 53 EOC adjacent tissues as control | OVCAR3, UWB1.289, SKOV3, CAOV3 and IOSE80 | miR-1271, miR-1252 and miR-203 | High levels of circ-ABCB10 were associated with poor differentiation, large tumor size and advanced FIGO stage and worse OS in EOC patients ↑↑ circ-ABCB10: ↑ proliferation and ↓ apoptosis | [70] |
circ-ABCB10 | – | OVCAR3, UWB1.289, SKOV3, CAOV3 and IOSE80 | miR-1271, Capn4/Wnt/β-catenin signaling | ↑↑ circ-ABCB10: ↑ proliferation, invasion, Capn4/Wnt/β-catenin signaling pathway, ↓ apoptosis via sponging miR-1271 | [71] |
circ-CSPP1 | 12 borderline tumors, 117 ovarian carcinomas tissues, 12 benign ovarian tissues and 15 normal ovarian tissues | AOV3, A2780, OVCAR3 | miR-1236-3p/ZEB1 axis | ∆ circ-CSPP1: ↓ cell growth, migration, invasion, and EMT process High levels of circ-CSPP1 were associated with correlated with FIGO staging and differentiation | [72] |
circ_0002711 | 54 pairs of tumor tissues and ANCTs/nude mice | SKOV3, OV90 and IOSE80 | miR-1244/ROCK1 axis | ∆ circ_0002711: ↓ cell viability, colony formation ability and aerobic glycolysis | [73] |
circE2F2 | – | OC tissues and cell lines | – | ↑↑ circE2F2: ↑ proliferation, cell growth, metastasis, and glucose metabolism by stabilizing the E2F2 mRNA High levels of circE2F2 could strengthen the stability of the E2F2 mRNA through binding to the HuR protein High levels of circE2F2 were correlated with poor OS in OC patients | [74] |
circHIPK2 | 46 pairs of tumor tissues and ANCTs/4–5-week-old female BALB/c-nude mice | SKOV3, A2780, SKOV3/DDP and A2780/DDP and IOSE80 | miR-338-3p/CHTOP axis | ∆ circHIPK2: ↓ cell proliferation, cell cycle entrance, migration and invasion in SKOV3/DDP and A2780/DDP cells and ↑ apoptosis and suppresses the 50% inhibitory concentration of DDP | [75] |
circ_0000745 | 50 pairs of tumor tissues and ANCTs/4-week-old BALB/c nude mice | CoC1, ES-2, SW626, SK-OV-3 and IOSE-80 | miR-3187-3p/ERBB4 axis and PI3K/AKT signaling pathway | ∆ circ_0000745: ↓ proliferation, aggressiveness, EMT process, and stemness of SK-OV-3 cells | [76] |